학술논문
P0898 : TD-6450, A next generation once-daily NS5A inhibitor, has potent antiviral activity following a 3-day monotherapy study in genotype 1 HCV infection
Document Type
Abstract
Author
Source
In Journal of Hepatology April 2015 62 Supplement 2:S680-S681
Subject
Language
ISSN
0168-8278